Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-1901-2025

Access Testosterone assay, Catalog Number 33560 Recall

Access Testosterone assay, Catalog Number 33560

FDA recall Class II

Ongoing

FDA lists this Class II recall for Access Testosterone assay, Catalog Number 33560. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-1901-2025
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
May 5, 2025
FDA report date
Jun 11, 2025
Quantity in commerce
70 units
Distribution
See key details
FDA cause
Equipment maintenance

What is being recalled?

Access Testosterone assay, Catalog Number 33560

Affected model & UDI checker

Search the exact identifiers published for Z-1901-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
33560Access Testosterone assay, Catalog Number 33560Check source noticeNot specified
Not specifiedAccess Testosterone assay, Catalog Number 33560Check source notice15099590231347
FDA code information

UDI-DI: 15099590231347; Serial Number: 538081

View the original FDA recall notice

Why was this product recalled?

Inadequate preventative maintenance (PM) performed on the scales of the RPL5 fill line, led to splashing (cross-contamination) between the wells of testosterone reagent packs lot 538081, which could potentially result in up to a 34% increase or a 23% decrease in patient results.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did BECKMAN COULTER, INC. take?

An URGENT MEDICAL DEVICE RECALL notification letter dated 4/23/25 was sent to customers. ACTION: Discontinue using and discard all remaining Access Testosterone reagent packs from the lot listed above. Beckman Coulter recommends performing a retrospective review on patient results generated with the Access Testosterone lot listed above and assessing the need for retesting. Contact your local Beckman Coulter representative for replacement product requests. Beckman Coulter is no longer distributing the affected Access Testosterone reagent pack lot number and has corrected the manufacturing issue that led to cross-contamination. Please share this information with your laboratory staff and retain this notification as part of your laboratory Quality System documentation. If you have forwarded any of the affected product listed above to another laboratory, please provide them a copy of this letter. So that we are assured you have received this important communication, please respond within 10 days in one of the following ways: Electronically, if you received this communication via email. Manually, complete and return the enclosed Response Form. If you have any questions regarding this notice, please contact our Customer Support Center: From our website: http://www.beckmancoulter.com If you need replacement product: o Complete the attached Replacement Order Form and email to [email protected] or fax to (866) 294-7850 OR o Call Client Services at (800) 526-3821

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology